AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, is pleased to announce a term sheet agreement has been signed between New Super Limited ("NSL"), and AlphaRx International Holdings Limited ("AIH"), a wholly owned subsidiary of AlphaRx Inc. ("AlphaRx"), for the purpose of funding AIH's ongoing business developments and commercialization of its licensed products in its pharmaceutical and consumer health (over-the-counter) product line in Asia.
